Stromatt Scott C 4
4 · Aptevo Therapeutics Inc. · Filed Feb 6, 2018
Insider Transaction Report
Form 4
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
- Exercise/Conversion
Common Stock
2018-02-03+27,381→ 174,576 total - Exercise/Conversion
Restricted Stock Unit
2018-02-03−27,381→ 46,430 total→ Common Stock (27,381 underlying)
Footnotes (2)
- [F1]Each RSU converts into the Issuer's common stock on a one-for-one basis.
- [F2]On August 3, 2016, the reporting person was granted 54,762 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018.